D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 19
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −89,515−100.0% | Sold out | Holders |
| Q4 2025 | 89,515 | $7.63M | <0.1% | +89,515 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −171,204−100.0% | Sold out | Holders |
| Q2 2025 | 171,204 | $13.4M | <0.1% | −703,202−80.4% | Reduced | Holders |
| Q1 2025 | 874,406 | $63.4M | 0.1% | −102,412−10.5% | Reduced | Holders |
| Q4 2024 | 976,818 | $72.3M | 0.1% | −6,398−0.7% | Reduced | Holders |
| Q3 2024 | 983,216 | $64.9M | 0.1% | +893,566+996.7% | Added | Holders |
| Q2 2024 | 89,650 | $8.28M | <0.1% | −177,934−66.5% | Reduced | Holders |
| Q1 2024 | 267,584 | $25.6M | <0.1% | +27,795+11.6% | Added | Holders |
| Q4 2023 | 239,789 | $18.3M | <0.1% | −183,440−43.3% | Reduced | Holders |
| Q3 2023 | 423,229 | $29.3M | <0.1% | −84,632−16.7% | Reduced | Holders |
| Q2 2023 | 507,861 | $47.9M | 0.1% | −2,520,545−83.2% | Reduced | Holders |
| Q1 2023 | 3,028,406 | $250.5M | 0.4% | +218,112+7.8% | Added | Holders |
| Q4 2022 | 2,810,294 | $209.7M | 0.4% | +2,367,796+535.1% | Added | Holders |
| Q3 2022 | 442,498 | $36.6M | 0.1% | +414,199+1,463.7% | Added | Holders |
| Q2 2022 | 28,299 | $2.69M | <0.1% | +9,906+53.9% | Added | Holders |
| Q1 2022 | 18,393 | $2.17M | <0.1% | −34,604−65.3% | Reduced | Holders |
| Q4 2021 | 52,997 | $6.87M | <0.1% | −180,423−77.3% | Reduced | Holders |
| Q3 2021 | 233,420 | $26.4M | <0.1% | −281,725−54.7% | Reduced | Holders |
| Q2 2021 | 515,145 | $53.4M | 0.1% | −528,706−50.6% | Reduced | Holders |
| Q1 2021 | 1,043,851 | $87.3M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.